Grade A++ Test bank for applied pharmacology for the dental hygienist 9th edition by elena_bablenis haveles with both questions and answers

TESTBANK ForApplied Pharmacologyforthe
f f f f f f




Dental Hygienist 9th Edition
f f f f




by Elena Bablenis Haveles, Chapters 1 - 26 A+
f f f f f f f f

,Chapter01:InformationSources, Regulatory Agencies, Drug Legislation, andPrescription Writing
f f f f f f f f f f




Haveles:AppliedPharmacology for theDental Hygienist,9thEdition
f f f f f f f f




MULTIPLE CHOICE f




1. Knowledge of pharmacologyaids the dental professional in f f f f f f f




a. obtaining a patient’s health history. f f f f



b. administering drugs in the office. f f f f




c. handling emergency situations. f f




d. selection of a nonprescription medication. f f f f



e. All of the above. f f f




ANSWER: E f




All of the choices are true. Because many of our patients are being treated with drugs, knowledge of
f f f f f f f f f f f f f f f f f




pharmacologyhelps in understanding and interpreting patients’ responses to health historyquestions.
f f f f f f f f f f f f




Knowledge of the therapeutic and adverse effects of medications obviously helps in their proper
f f f f f f f f f f f f f f




administration in the office. Emergency situations may be caused by drugs or treated by drugs; thus,
f f f f f f f f f f f f f f f f




knowledge of pharmacology is of great help, especially because a rapid response is sometimes required.
f f f f f f f f f f f f f f f




A clear understanding of the concepts of drug action, drug handling by the body, and drug interactions
f f f f f f f f f f f f f f f f f




will allow the dental practitioner to make proper judgments and grasp the concepts relevant to new drug
f f f f f f f f f f f f f f f f f




therapies on the market.
f f f f




DIF: Application
REF: Role of theDental Hygienist (Medication/Health History), Role of theDental Hygienist (Medication
f f f f f f f f f f f f f



Administration), Role of the Dental Hygienist (Emergency Situations), Role of the Dental Hygienist
f f f f f f f f f f f f f



(Nonprescription Medication) | pp. 2-3
f OBJ: 1 f f f f



TOP: NBDHE, 6.0. Pharmacologyf f f




2. Which of the following statements is true regarding planning appointments?
f f f f f f f f f




a. Whether or not patients are taking medication for systemic diseases is of little f f f f f f f f f f f f




consequence in the dental office. f f f f




b. Asthmatic patients should have dental appointments in the morning. f f f f f f f f




c. Diabetic patients usually have fewer problems with a morning appointment f f f f f f f f f




compared with afternoon appointments. f f f



d. Both B and C are true. f f f f f




ANSWER: D f




Asthmatic patients who experience dental anxietyshould schedule their appointments when theyare not
f f f f f f f f f f f f f




rushed or under pressure early in the morning. Diabetic patients usually have relatively fewer problems
f f f f f f f f f f f f f f f




with a morning appointment. Patients taking medication for systemic diseases mayrequire special
f f f f f f f f f f f f f




handling in the dental office.
f f f f f

, DIF: Comprehension
REF: Role of theDental Hygienist (Appointment Scheduling) |p. 3
f f f f f f f f f f



OBJ: 1
f f TOP: NBDHE, 6.0. Pharmacology f f f




3. Nutritional or herbal supplements f f f




a. carrythe U.S. Food and Drug Administration (FDA) approval for disease states.
f f f f f f f f f f f



b. are not drugs. f f




c. can cause adverse effects. f f f



d. will not interact with other drugs the patient may be taking.
f f f f f f f f f f




ANSWER: C f




Nutritional or herbal supplements are quite capable of causing adverse effects. The majority of
f f f f f f f f f f f f f




nutritional or herbal supplements do not carry FDA approval for treating disease states. These
f f f f f f f f f f f f f f




supplements are drugs and can cause adverse effects and interact with different drugs.
f f f f f f f f f f f f f




DIF: Comprehension
f f



REF: Role of the Dental Hygienist (Nutritional or Herbal Supplements) |p. 3
f f f f f f f f f f f f



OBJ: 1
f f TOP: NBDHE, 6.0. Pharmacology f f f




4. Whichtype of drug name usually begins with a lowercase letter?
f f f f f f f f f f




a. Brand name f



b. Code name f




c. Genericname f



d. Trade name f




ANSWER: C f




Before anydrug is marketed, it is given a generic name that becomes the “official” name ofthe drug. Each
f f f f f f f f f f f f f f f f f f f




drug is assigned only one generic name selected by the U.S. Adopted Name Council, and the name is not
f f f f f f f f f f f f f f f f f f f




capitalized. The brand name is equivalent to the trade name and is capitalized. Although the brand name is
f f f f f f f f f f f f f f f f f f




technicallythe name ofthe companymarketing the product, this term is often used interchangeably with
f f f f f f f f f f f f f f f f




the trade name. The code name is the initial term used within a pharmaceutical company to refer to a drug
f f f f f f f f f f f f f f f f f f f f




while it is undergoing investigation and is often a combination of capital letters and numbers, the letters
f f f f f f f f f f f f f f f f f




representing an abbreviation of the company name.
f f f f f f f




DIF: Comprehension REF: DrugNames |p. 4 f f f f f



OBJ: 3
f f TOP: NBDHE, 6.0. Pharmacology f f f




5. A drug’s generic name is selected bythe
f f f f f f f




a. pharmaceutical company manufacturing it. f f f



b. Food and Drug Administration (FDA). f f f f




c. U.S. Adopted Name Council. f f f



d. Federal Patent Office. f f

, ANSWER: C f




Each drug is assigned only one generic name (e.g., ibuprofen). It is selected by the U.S. Adopted Name
f f f f f f f f f f f f f f f f f




Council. The generic name is not selected by the FDA or the Federal Patent Office. The pharmaceutical
f f f f f f f f f f f f f f f f f




companymanufacturing the drug clearlyhas an influence on the generic name given its drug, but the final
f f f f f f f f f f f f f f f f f f




decision is not the company’s.
f f f f f




DIF: Recall REF: Drug Names | p. 4 f f f f f OBJ: 3 f



TOP: NBDHE, 6.0. Pharmacology
f f f f




6. Which of the following is true concerning generic and trade names of drugs?
f f f f f f f f f f f f




a. A drug mayonly have one generic name and one trade name.
f f f f f f f f f f f



b. A drug mayonly have one generic name, but it may have several trade names.
f f f f f f f f f f f f f f



c. A drug mayhave several generic names, but it mayonlyhave one trade name.
f f f f f f f f f f f f f f



d. Adrug mayhave several generic names and several trade names.
f f f f f f f f f f




ANSWER: B f




Each drug has only one generic name but may have several trade names. For each drug, there is only one
f f f f f f f f f f f f f f f f f f f




generic name. It is not capitalized, and it becomes the “official” name of the drug. The pharmaceutical
f f f f f f f f f f f f f f f f f




company discovering the drug gives the drug a trade name. The trade name is protected bythe Federal
f f f f f f f f f f f f f f f f f f




Patent Law for 20 years from the earliest claimed filing date, plus patent term extensions. Although the
f f f f f f f f f f f f f f f f f




brand name is technically the name ofthe companymarketing the product, it is often used interchangeably
f f f f f f f f f f f f f f f f f




with the trade name.
f f f f




DIF: Comprehension REF: DrugNames |p. 4 f f f f f



OBJ: 3
f f TOP: NBDHE, 6.0. Pharmacology f f f




7. Two drugsthat are found to be chemicallyequivalent, but not biologicallyequivalent or
f f f f f f f f f f f f f




therapeutically equivalent are said to differ in
f f f f f f f




a. potency.
b. efficacy.
c. bioavailability.
d. therapeutic index. f




ANSWER: C f




A preparation can be chemically equivalent yet not biologically or therapeutically equivalent. These
f f f f f f f f f f f f




products are said to differ in their bioavailability. The potencyof a drug is a function ofthe amount of drug
f f f f f f f f f f f f f f f f f f f f f




required to produce an effect. The efficacy is the maximum intensity of effect or response that can be
f f f f f f f f f f f f f f f f f f




produced by a drug. The therapeutic index is the ratio of the lethal dose for 50% of the experimental
f f f f f f f f f f f f f f f f f f f




animals divided by the effective dose for 50% of the experimental animals. If the value of the therapeutic
f f f f f f f f f f f f f f f f f f




index is small, toxicity is more likely.
f f f f f f f




DIF: Recall REF: DrugNames (DrugSubstitution) |p. 5 f f f f f f f



OBJ: 4
f f TOP: NBDHE, 6.0. Pharmacology f f f